切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 298 -301. doi: 10.3877/cma.j.issn.1674-3946.2025.03.018.

论著

结肠癌根治术与CME对结肠癌患者血清miR-21、miR-25-3p表达的影响比较
钱征1, 吴泉霖1,()   
  1. 1. 710100 西安,西安国际医学中心医院胃肠外科
  • 收稿日期:2024-10-31 出版日期:2025-06-26
  • 通信作者: 吴泉霖
  • 基金资助:
    陕西省重点研发计划项目(2023-YBSF-546)

Comparison of influence of radical resection of colon cancer and CME on expressions of serum miR-21 and miR-25-3p in patients with colon cancer

Zheng Qian1, Quanlin Wu1,()   

  1. 1. Department of Gastrointestinal Surgery,Xi'an International Medical Center Hospital,Xi'an Shaanxi Province 710100,China
  • Received:2024-10-31 Published:2025-06-26
  • Corresponding author: Quanlin Wu
引用本文:

钱征, 吴泉霖. 结肠癌根治术与CME对结肠癌患者血清miR-21、miR-25-3p表达的影响比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 298-301.

Zheng Qian, Quanlin Wu. Comparison of influence of radical resection of colon cancer and CME on expressions of serum miR-21 and miR-25-3p in patients with colon cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 298-301.

目的

探究结肠癌根治术与完整结肠系膜切除术(CME)对结肠癌患者血清miR-21、miR-25-3p表达的影响比较。

方法

纳入2021年6月至2023年6月收治的Ⅰ-Ⅲ期结肠癌患者,根据接受手术方式不同分为根治组(接受开腹结肠癌根治术)和CME组(接受腹腔镜下完整结肠系膜切除术),经倾向性匹配评分排除基线资料混杂因素影响,最终根治组与CME组各获得75例基线资料可比的患者。利用SPSS 27.0软件分析数据,并发症等计数资料以[例(%)]表示,采取χ2检验;肠管切除长度、miR-21及miR-25-3p表达量等计量资料以(±s)表示,采取独立样本t检验;生存分析采用Kaplan-Meier法并行Log-Rank检验。P<0.05即具有统计学意义。

结果

CME组患者术中出血量显著低于根治组(P<0.05),引流管拔除时间、排气时间、住院时间显著短于根治组(P<0.05),淋巴结清扫数目显著多于根治组(P<0.05),而两组的手术时间及肠管切除长度无显著差异(P>0.05);CME组患者并发症发生率显著低于根治组(P<0.05);术后1周,两组患者miR-21及miR-25-3p表达水平显著下降(P<0.05),CME组显著低于根治组(P<0.05);通过Kaplan-Meier分析显示,两组患者的累积总生存率(100.0% vs. 98.7%)及累积无疾病进展生存率(97.3% vs. 90.7%)比较,差异均无统计学意义(P>0.05)。

结论

相较于结肠癌根治术,CME治疗结肠癌更利于患者恢复,且并发症少,可有效降低潜在癌症转移风险,术后短期预后效果较好,值得推荐。

Objective

To explore and compare the influence of radical resection of colon cancer and complete mesocolic excision (CME) on the expressions of serum miR-21 and miR-25-3p in patients with colon cancer (CC).

Methods

Patients with stage I-III CC were included from June 2021 to June 2023.According to different surgical methods,they were divided into radical resection group (open radical resection of colon cancer) and CME group (laparoscopic CME).The propensity matching score was used to exclude the influence of confounding factors of baseline data.Finally,75 patients with comparable baseline data were obtained in radical resection group and CME group.SPSS 27.0 software was used for data analysis.Enumeration data such as complications were expressed by[ cases (%)] and χ2 test was performed.Measurement data such as bowel resection length and expressions of miR-21 and miR-25-3p were expressed as (±s) by adopting independent sample t test.Kaplan-Meier method and Log-Rank test were used for survival analysis.P<0.05 was statistically significant.

Results

The intraoperative blood loss in CME group was significantly less than that in radical resection group (P<0.05),and the drainage tube removal time,exhaust time and hospitalization time were significantly shorter than those in radical resection group (P<0.05),and the number of lymph node dissection was significantly more (P<0.05),but there were no significant differences in the surgical time and bowel resection length between groups (P>0.05).The incidence rates of complications in CME group were significantly lower than those in radical resection group (P<0.05).At 1 week after surgery,the expression levels of miR-21 and miR-25-3p in the two groups were decreased significantly (P<0.05),and the expression levels were significantly lower in CME group than those in radical resection group (P<0.05).Kaplan-Meier analysis showed that there were no statistical differences in cumulative overall survival rate (100.0% vs. 98.7%) and progression-free survival rate (97.3% vs. 90.7%) between groups (P>0.05).

Conclusion

Compared with radical resection of colon cancer,CME is more conducive to the recovery of patients with CC,and the latter one has fewer complications and can effectively reduce the risk of potential cancer metastasis and has better postoperative short-term prognosis.

表1 两组结肠癌手术患者一般资料比较
表2 两组结肠癌手术患者围手术期指标对比(±s
表3 两组结肠癌手术患者miR-21、miR-25-3p表达水平对比(±s
[1]
György A,István G.Surgery of the colon cancer-Expected standards[J].Magy Seb,2023,76(1): 24-27.
[2]
李若凡,高旭,孙立新.结肠癌根治术中洛铂腹腔灌洗化疗预防术后复发的临床研究[J].川北医学院学报,2022,37(06):772-775,792.
[3]
宋志岗,连彦军,刘帅,等.不同手术入路的腹腔镜右半结肠癌CME术临床疗效对比[J/CD].中华普外科手术学杂志(电子版),2021,15(05): 535-538.
[4]
张聃,王毅,冯文迪,等.完整结肠系膜切除术与传统根治术治疗结肠癌对患者生存期的影响观察[J/CD].中华普外科手术学杂志(电子版),2024,18(03): 279-282.
[5]
He B,Zhao Z,Cai Q,et al.miRNA-based biomarkers,therapies,and resistance in Cance[rJ].Int J Biol Sci.2020,16(14): 2628-2647.
[6]
中国研究型医院学会消化道肿瘤专业委员会,中国医师协会外科医师分会多学科综合治疗专业委员会.结肠癌多学科综合治疗协作组诊疗模式专家共识[J].中国实用外科杂志,2017,37(01): 44-45.
[7]
蒋汉卿,何进伟,罗水祥,等.腹腔镜下结肠癌根治术与开腹结肠癌根治术近远期疗效的对比分析[J].肿瘤预防与治疗,2020,33(3): 248-252.
[8]
De Lange G,Davies J,Toso C,et al.Complete mesocolic excision for right hemicolectomy: an updated systematic review and metaanalysis[J].Tech Coloproctol,2023,27(11): 979-993.
[9]
刘月生,曾海锋,唐志良,等.不同入路腹腔镜完整结肠系膜切除术治疗右半结肠癌的临床效果和预后的对比研究[J/CD].中华普通外科学文献(电子版),2022,16(02): 111-115.
[10]
王秀洪,尹露,殷小容,等.舒芬太尼联合氟比洛芬酯和右美托咪定用于开腹结直肠癌根治术后患者静脉自控镇痛的有效性和安全性[J].中国医药,2022,17(12): 1817-1821.
[11]
周国才,董晶,陈旭,等.腔镜下完整结肠系膜切除术治疗右半结肠癌近期及远期临床疗效评价[J].重庆医学,2024,53(S01): 93-95.
[12]
黄金广,杨勇,胡雄辉,等.不同BMI结直肠癌患者手术效果、预后差异性及术后并发早期炎症性肠梗阻的影响因素分析[J].临床和实验医学杂志,2024,23(14): 1505-1509.
[13]
张盛,崇慧峰,焦瑞宝,等.CD64指数联合IL-1β、TLR4在诊断结直肠癌患者术后感染中的临床价值[J].临床检验杂志,2024,42(03): 177-181.
[14]
吴子健,周思成,陈海鹏,等.腹腔镜与开腹二次手术治疗腹腔镜结直肠癌术后吻合口漏的疗效比较[J].中国医刊,2020,55(01): 47-51.
[15]
张洪志,任远,姚国忠,等.右半结肠癌根治术后腹腔淋巴漏的危险因素分析[J].中南医学科学杂志,2021,49(04): 481-484.
[16]
张丽,凌晨,沈轶骊.血清microRNA-21、microRNA-193a-3p表达与结直肠癌患者手术预后的关系[J].中国现代医学杂志,2024,34(05): 1-6.
[17]
陈斌,仲崇浩,方昭,等.血清miR-25-3p、CXCL12水平与非小细胞肺癌患者胸腔镜肺叶切除术后预后的关系分析[J].现代肿瘤医学,2024,32(09): 1643-1648.
[1] 李怡泉, 谢宇斌, 胡宏, 张燕茹, 陈图锋. 基于生物信息学分析HDAC8在结肠癌中的临床意义及其与免疫浸润的关系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 275-281.
[2] 何可可, 顾海扬, 肖姝, 韦琪, 李鑫玉. 腹腔镜保留回盲部右半结肠切除术治疗右半结肠癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 149-152.
[3] 陈宝鹤, 张文卓, 王隽. 头尾侧联合入路腹腔镜右半结肠癌根治术的近中期临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 153-156.
[4] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[5] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[6] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[7] 孙龙凤, 侯高峰, 王幼黎, 刘磊. 腹腔镜下右半结肠癌D3根治术中SMA或SMV入路的选择[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 438-441.
[8] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[9] 王开宇, 郭天宇, 李娜, 白静慧, 张雷, 金号然, 张睿, 刘也夫. 机器人辅助腹腔镜左半结肠切除联合肝右后叶转移瘤切除一例(附视频)[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(02): 189-192.
[10] 曾兵, 李锦宏, 辛海洋, 刘付恒, 元志龙, 甘文昌, 蔡灿锋, 李英儒. KDM4C 在结肠癌中的表达及临床意义[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(01): 53-61.
[11] 关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[12] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[14] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要